Capricorn Systems Global Solutions Limited has formally notified BSE Limited that it does not qualify as a Large Corporate under the applicable SEBI regulations for the upcoming financial year. The confirmation addresses regulatory compliance requirements outlined in specific SEBI guidelines governing corporate classifications.

Regulatory Compliance Declaration

Managing Director Manmohan Rao Suddhala submitted the formal confirmation to BSE on April 13, 2026, stating that the company does not fall under the purview of Large Corporates as defined in SEBI Circular SEBI/HO/DDHS/CIR/P/2018/144 dated November 26, 2018. The declaration specifically covers the financial year 2026-2027 and references Para 2.2 of the aforementioned SEBI circular.

Corporate Classification Impact

The confirmation ensures that Capricorn Systems Global Solutions Limited maintains compliance with SEBI's regulatory framework regarding corporate classification. Companies are required to assess and declare their status under various SEBI circulars to ensure appropriate regulatory treatment and compliance obligations.

Management Declaration

The formal communication was digitally signed by Managing Director Manmohan Rao Suddhala on April 13, 2026, at 14:34:14 +05'30'. The declaration serves as an official record for BSE's listing department and ensures transparency in regulatory compliance matters. This proactive disclosure demonstrates the company's commitment to maintaining proper regulatory standing and meeting all applicable SEBI requirements for the specified financial year.

Capricorn Systems Global Solutions Limited has successfully concluded its board meeting on April 11, 2026, approving the scheme of amalgamation with Radical Bio-Organics Limited. The meeting, which commenced at 4:30 p.m. and concluded at 5:05 p.m., marked the completion of the corporate restructuring initiative previously announced on April 08, 2026.

Board Meeting Outcome and Approval

The Board of Directors formally considered and approved the Scheme of Amalgamation of Radical Bio-Organics Limited (Transferor Company) with and into Capricorn Systems Global Solutions Limited (Transferee Company) along with their respective shareholders and creditors. The approval was communicated to BSE Limited under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Financial Profile and Business Operations

The amalgamation brings together two entities with complementary business profiles. Capricorn Systems Global Solutions Limited, the listed transferee company, operates primarily in import, export, and commodity trading including crops, minerals, textiles, food and beverages, and manufactured goods, with minimal revenue from software services.

Radical Bio-Organics Limited specializes in manufacturing Extra Neutral Alcohol (ENA), Impure Spirit (IS), Dried Distiller Grain with Soluble (DDGS), and Solid Carbon Dioxide (CO₂).

Strategic Rationale and Benefits

The amalgamation is designed to achieve strategic business diversification and risk mitigation by providing the combined entity substantial entry into the high-growth manufacturing sector of distillery products. This move reduces reliance on volatile commodity trading business while offering more predictable revenue streams.

Key expected benefits include:

• Operational Synergies: Optimized procurement through consolidated purchasing power, streamlined logistics, and rationalization of common functions
• Cost Synergies: Elimination of overlapping functions in administration, finance, human resources, and information technology
• Financial Benefits: Strengthened financial profile with higher revenues, improved profitability, and enhanced cash flows
• Market Position: Enhanced market capitalization and improved share liquidity through diversification

Share Exchange and Implementation

The approved scheme establishes a 1:1 share exchange ratio, where shareholders of Radical Bio-Organics Limited will receive one fully paid-up equity share of Capricorn Systems Global Solutions Limited for every one fully paid-up equity share held in the transferor company. Upon scheme effectiveness, all equity shares of Radical Bio-Organics Limited will stand extinguished.

The transaction does not fall within related party transactions, ensuring arm's length compliance. The combined entity's IT department will play a crucial role in supporting both commodity trading operations through real-time market tracking and manufacturing processes through automated production and supply chain management systems.